Osiris Therapeutics, Inc. to Present at the Seventh Annual JMP Securities Healthcare Conference

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the Seventh Annual JMP Securities Healthcare Conference on Friday, July 13, 2012 at 10:00 a.m. ET in New York City.
MORE ON THIS TOPIC